Retrolaminar Block Versus Tab Block in Abdomioasty

Block Clinical Trial

Official title:

Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06265402
• Other study ID #: 36264
• Status: Recruiting
• Phase: N/A
• Start date: January 15, 2024
• Est. completion date: December 15, 2025

Study information

• Verified date: February 2024
• Source: Tanta University
• Contact: Hadeel Elsagheer, Master
• Phone: 01090884208
• Email: Dodoelsagheer[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery

Description:

Pain from intra abdominal surgery is a combination of somatic and visceral pain visceral pain transmitted by autonomic nervous system via sympathetic fibers from plexuses in close proximity to the viscera them selves Regional anesthetic are commonly used to prevent or minimize these side effect the use of ultra sound nerve block are commonly use as apart of multimodal post operative analgesia The tab block is used to decrease the need of post operative analgesia in patient undergoing abdominal plastic surgery It was found an alternative approach to para vertebral block the retro laminar block is performed with us guided imaging to reduce pain post operative and need analgesia

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 90
• Est. completion date: December 15, 2025
• Est. primary completion date: October 15, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery

Exclusion Criteria:

• patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder

Related Conditions & MeSH terms

• Block

Intervention

Procedure:
• Tab block versus retrolaminar block in abdominal plastic surgery
i inject 20ml bupivacine either 4mg dead in each side

Locations

Country	Name	City	State
Egypt	TantaU U	Tanta

Sponsors (1)

Lead Sponsor	Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total dose of morphine consumption in the first postoperative 24hours	Total dose of morphine consumption in the first postoperative 24hours	First 24hours